In the Boardroom
Refine Search
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
French pharma company Ipsen today announced that Claude Bertrand, executive vice president, R&D, chief scientific officer, will depart Ipsen on January, 2017, to join another company. 12 December 2016
Pharmaceutical
Lisa Anson, president of AstraZeneca UK and Ireland, has been elected as the next president of trade group the Association of the British Pharmaceutical Industry (ABPI). 7 December 2016
Generics
Israel’s Teva Pharmaceutical Industries says that Dipankar Bhattacharjee has been appointed president and chief executive, Global Generic Medicines Group, effective Monday. 6 December 2016
Pharmaceutical
After seven years as chief executive of ViiV Healthcare, Dr Dominique Limet will step down at the end of March 2017. 5 December 2016
Biotechnology
Last week, US biotech major Gilead Sciences terminated its licensing deal with GlobeImmune to develop a hepatitis-B (HBV) drug, GS-4774, and returned rights to the drug. 22 November 2016
Pharmaceutical
Experienced industry executive Hervé Gisserot is to become head of pharmaceuticals for the newly-created Asia Pacific Region at UK pharma major GlaxoSmithKline. 22 November 2016
Biotechnology
US biotech major Gilead Sciences has promoted James Meyers, who joined the company back in 1996. 17 November 2016
Biotechnology
US biotech major Biogen has named two members to the executive management team of Bioverativ, its planned spin-off company focused on the discovery, research, development and commercialization of treatments for hemophilia and other blood disorders. 16 November 2016
Generics
Ireland-incorporated drugmaker Endo International today announced the appointment of two executive leadership team members. 7 November 2016
article
French drugmaker Ipsen (Euronext: IPN) has appointed Aymeric Le Chatelier as executive vice president and chief financial officer. 4 November 2016
Pharmaceutical
Immuno-oncology company PsiOxus Therapeutics may opt for an initial share offering in 2017, though the company is not looking to go public anytime sooner, chief executive John Beadle told The Pharma Letter in an exclusive interview. 4 November 2016
Pharmaceutical
Roche Pharmaceuticals Asia Pacific says that Dr Christiane Hamacher has assumed the role of head of Asia Pacific (APAC), joining Swiss pharma giant Roche’s global leadership team 1 November 2016
Biotechnology
French biotech firm Erytech Pharma today announced the appointments of Dr Alexander Scheer, as the company’s chief scientific officer and Jean-Sébastien Cleiftie, as chief business officer. 27 October 2016
Biotechnology
Kite Pharma’s today announced the appointment of Chris Nowers as its head of Europe. He will be based in London. 13 October 2016
Pharmaceutical
Swiss drug developer EffRx Pharmaceuticals today said it has named Lorenzo Bosisio appointed as chief executive effective July 1st, 2016. 12 October 2016
Pharmaceutical
The board of directors of the Swiss Galenica Group has designated Stefan Schulze, currently chief executive of group company Vifor Fresenius Medical Care Renal Pharma (VFMCRP), as chief operating officer and president of the executive committee of Vifor Pharma. 6 October 2016
Pharmaceutical
Astellas Pharma has appointed Steven Benner as senior vice president and therapeutic area head for oncology, and promoted Anne Keating to vice president of clinical science for oncology, within the company's development organization. 6 October 2016
Pharmaceutical
Santhera Pharmaceuticals has appointed Kristina Timdahl as chief medical officer and head of development and a member of the executive management with effect from January 1, 2017. 5 October 2016
Pharmaceutical
Mariano Balaguer has been named the chief financial officer of USA-based Taro Pharmaceutical Industries. 4 October 2016
Pharmaceutical
Robert Mulroy, the chief executive of USA-based Merrimack Pharmaceuticals has resigned after 17 years in the role as the company undergoes a major restructuring which will see its workforce cut by 22%. 4 October 2016
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze